Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
about
Pheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesHigh-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paragangliomaRare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Current views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaAnti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.Molecular markers of paragangliomas/pheochromocytomasThe NF1 somatic mutational landscape in sporadic human cancers.The NF1 gene revisited - from bench to bedside.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentWhole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated geneComprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientProfiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from PheochromocytomaSomatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations.Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.Rethinking pheochromocytomas and paragangliomas from a genomic perspective.PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma.The genomic landscape of phaeochromocytoma.The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma.When should genetic testing be performed in patients with neuroendocrine tumours?Activating FGFR1 Mutations in Sporadic Pheochromocytomas.Genetic mechanisms of human hypertension and their implications for blood pressure physiology.The adrenal medulla and extra-adrenal paraganglia: then and now.Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.Exome analysis of carotid body tumor.Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma
P2860
Q26782841-A81D2B47-EF83-4A5D-9B93-EB45DD93FD67Q28541862-CD3E8187-8AB6-47D6-8A88-550BB78FB996Q33570108-49C83FFB-9875-41F8-9028-87280C1ACB96Q33590969-E42783AF-829A-49C6-B5A1-D8C4845E331FQ33638286-FEE8D28C-5612-485A-9367-AFFB010A8793Q33649025-E0B22BEA-2419-4044-9FE7-596734EFABC0Q33823452-3B459858-ABF1-4A93-9E95-F0673AB14073Q34227509-6B813A66-0B33-4994-A6EC-955EAF2F5443Q34410500-5E6BDEF4-B35D-4F30-BC8A-2182F1DA1EB9Q34478820-405E11C4-6A91-44AF-9933-63F05AD8C062Q34680693-A56E6D8C-2D5F-4E28-9759-62B2E7EF6CF3Q34998940-7419ABF0-56EB-47E8-9D95-BE23BF051E1DQ35160825-61CEEBDE-3DB1-40E0-97F6-121697F6DBF9Q35182111-35CF7D79-8FCE-472F-9A11-D38B91BF68ECQ35323457-77DCE460-A89B-48CC-A68A-4BA17E409036Q35731152-0F2FAA80-CDFB-4C8E-B2E9-C789EF1C2690Q35837219-AE3573F4-3821-492D-81AE-32179C13D210Q37025126-6F540DF7-9A3F-47E0-A6F2-8E1A8EF05C33Q37505830-C62DD0F0-4434-43FB-BF23-0502BF594475Q37714945-55B2063F-DEDA-4099-A77D-6CBF2D5A20B8Q38106904-5FE3970B-C0A7-41B4-8A87-2D2EB0BC139CQ38266745-526694D9-A639-4CD2-9C09-4FB5D02CD786Q38509463-D8FD2950-6F5D-4710-B1A8-AEAAACBCE2CEQ38759395-897ED9F7-2C03-49C2-A206-4F91D917155EQ38801063-8654CB08-8FC3-457B-AA39-F367D258EF83Q39011468-F2D178B5-D93A-4ED1-BA8E-BD2B3612E2ABQ39400158-3A7EB075-B782-4EFA-ABFE-E8353F746B0AQ41643771-09B38E11-2E16-4523-B330-4C0987D7B9F3Q41975304-D8E8B960-1B64-495C-BB99-087AE1FBB10DQ43481604-1A31282C-1660-4A31-9586-FACAD76702BAQ47336402-38A7A295-6EF0-43E6-9B37-C8FF9B643A7CQ47921456-7715A99B-953E-4CB7-BC4F-BDD4041954DDQ47959074-6C28FC7A-6F59-4699-8E94-B81412477A00Q48100826-F927235C-3F95-4BAF-8126-4071FDFDF3BCQ48110909-22962B3C-C451-4E3E-B1C6-BC21D5C3456DQ49174438-FEB5AB1A-4AD8-43E9-95FE-D76AAE0DA245Q52674249-10C60BAB-9E6B-4906-A493-B8EF3C9C0B6CQ54976476-A3CEC6A6-4C9A-4ABF-8A78-DEEA716D5377Q54987382-1000DC8B-AA04-48C8-916B-AA51385B5AD7Q58553604-8D8D43CF-BB2A-44FC-A759-8888DEE9BD68
P2860
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
description
article
@en
im September 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2012
@uk
name
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@en
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@nl
type
label
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@en
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@nl
prefLabel
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@en
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@nl
P2093
P2860
P50
P356
P1476
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
@en
P2093
Alexandre Buffet
Béatrice Parfait
Céline Loriot
Dominique Vidaud
Ingrid Laurendeau
Laurence Valeyrie-Allanore
Nasséra Abermil
Nelly Burnichon
P2860
P304
P356
10.1093/HMG/DDS374
P577
2012-09-06T00:00:00Z